- Home
- SOHU vs PRTA Comparison
SOHU vs PRTA Comparison
Compare SOHU & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOHU
- PRTA
- Stock Information
- Founded
- SOHU 1996
- PRTA 2012
- Country
- SOHU China
- PRTA Ireland
- Employees
- SOHU N/A
- PRTA N/A
- Industry
- SOHU EDP Services
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- SOHU Technology
- PRTA Health Care
- Exchange
- SOHU Nasdaq
- PRTA Nasdaq
- Market Cap
- SOHU 468.1M
- PRTA 472.1M
- IPO Year
- SOHU 2000
- PRTA N/A
- Fundamental
- Price
- SOHU $15.77
- PRTA $8.06
- Analyst Decision
- SOHU Strong Buy
- PRTA Buy
- Analyst Count
- SOHU 1
- PRTA 10
- Target Price
- SOHU $20.00
- PRTA $12.29
- AVG Volume (30 Days)
- SOHU 71.7K
- PRTA 869.0K
- Earning Date
- SOHU 11-11-2025
- PRTA 11-11-2025
- Dividend Yield
- SOHU N/A
- PRTA N/A
- EPS Growth
- SOHU N/A
- PRTA N/A
- EPS
- SOHU 4.10
- PRTA N/A
- Revenue
- SOHU $548,588,000.00
- PRTA $10,341,000.00
- Revenue This Year
- SOHU N/A
- PRTA N/A
- Revenue Next Year
- SOHU $2.29
- PRTA $602.32
- P/E Ratio
- SOHU $3.82
- PRTA N/A
- Revenue Growth
- SOHU N/A
- PRTA N/A
- 52 Week Low
- SOHU $7.79
- PRTA $4.32
- 52 Week High
- SOHU $17.24
- PRTA $22.41
- Technical
- Relative Strength Index (RSI)
- SOHU 52.34
- PRTA 49.02
- Support Level
- SOHU $15.49
- PRTA $8.10
- Resistance Level
- SOHU $16.21
- PRTA $8.50
- Average True Range (ATR)
- SOHU 0.49
- PRTA 0.33
- MACD
- SOHU -0.08
- PRTA -0.10
- Stochastic Oscillator
- SOHU 38.74
- PRTA 3.45
About SOHU Sohu.com Limited
Sohu.com Ltd provides online media, games, and search products and services on PCs and mobile devices in China. The company operates in Sohu and Changyou segments. Sohu is an online media content and services provider. Through its social features, Sohu also enables users to generate and distribute content, as well as interact with each other on a platform. Changyou is an online game developer and operator. It generates maximum revenue from the Changyou segment.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.